Approval · Notice of Compliance 14650 · 2013
COSMEGEN: Notice of Compliance 14650
Issued August 15, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14650
- Date
- August 15, 2013
- Company
- Recordati Rare DiseasesPuteaux, France
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative merger-buyout
- Therapeutic class
- Actinomycin antibiotic; antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COSMEGEN | 00213071 | Marketed |
Medicinal ingredients
- DACTINOMYCIN 0.5 MG per VIAL